The healthcare AI startup, OpenEvidence, has raised 200 million in a new funding round. This places their valuation at 6 billion. The funding round was led by Google Ventures, with participation from Sequoia, Kleiner Perkins, Thrive Capital, Coatue, and others.
OpenEvidence is often described as ChatGPT for doctors, but it focuses on aggregating and, just as importantly, verifying medical research. In this way, it enables clinicians to access evidence-based guidance for patient care, and pretty quickly. The startup provides The New England Journal of Medicine and JAMA with reliable and up-to-date information, having signed content agreements with them as well. This is a big deal if you look at the recent exposure of researchers falsifying data.
The funding will be used to support global expansion, enhance AI capabilities, and accelerate the platforms integration into hospitals and clinics all over the world.
